Tat-βsyn-degron (trifluoroacetate salt) |
An α-synuclein knockdown peptide; binds to recombinant α-synuc… |
5 mg |
37442-5 |
More Info
|
Tat-CBD3A6K (trifluoroacetate salt) |
A peptide; prevents decreases in the paw withdrawal threshold in a rat mod… |
1 mg |
37449-1 |
More Info
|
Tat-CBD3A6K (trifluoroacetate salt) |
A peptide; prevents decreases in the paw withdrawal threshold in a rat mod… |
10 mg |
37449-10 |
More Info
|
Tat-CBD3A6K (trifluoroacetate salt) |
A peptide; prevents decreases in the paw withdrawal threshold in a rat mod… |
25 mg |
37449-25 |
More Info
|
Tat-CBD3A6K (trifluoroacetate salt) |
A peptide; prevents decreases in the paw withdrawal threshold in a rat mod… |
5 mg |
37449-5 |
More Info
|
Tat-CBD3 (trifluoroacetate salt) |
An inhibitor of the Cav2.2-CRMP2 protein-protein interaction; inhibits the… |
1 mg |
37448-1 |
More Info
|
Tat-CBD3 (trifluoroacetate salt) |
An inhibitor of the Cav2.2-CRMP2 protein-protein interaction; inhibits the… |
10 mg |
37448-10 |
More Info
|
Tat-CBD3 (trifluoroacetate salt) |
An inhibitor of the Cav2.2-CRMP2 protein-protein interaction; inhibits the… |
25 mg |
37448-25 |
More Info
|
Tat-CBD3 (trifluoroacetate salt) |
An inhibitor of the Cav2.2-CRMP2 protein-protein interaction; inhibits the… |
5 mg |
37448-5 |
More Info
|
Tat-CIRP (trifluoroacetate salt) |
A peptide inhibitor of the MD-2-CIRP protein-protein interaction; binds to… |
1 mg |
37446-1 |
More Info
|
Tat-CIRP (trifluoroacetate salt) |
A peptide inhibitor of the MD-2-CIRP protein-protein interaction; binds to… |
10 mg |
37446-10 |
More Info
|
Tat-CIRP (trifluoroacetate salt) |
A peptide inhibitor of the MD-2-CIRP protein-protein interaction; binds to… |
5 mg |
37446-5 |
More Info
|
Tat-Gap 19 (trifluoroacetate salt) |
A peptide inhibitor of Cx43 hemichannels; inhibits glutamate-induced ATP r… |
1 mg |
36729-1 |
More Info
|
Tat-Gap 19 (trifluoroacetate salt) |
A peptide inhibitor of Cx43 hemichannels; inhibits glutamate-induced ATP r… |
5 mg |
36729-5 |
More Info
|
Tat-Gap 19 (trifluoroacetate salt) |
A peptide inhibitor of Cx43 hemichannels; inhibits glutamate-induced ATP r… |
500 µg |
36729-500 |
More Info
|
Tat-M2NX (trifluoroacetate salt) |
A peptide TRPM2 antagonist; inhibits hydrogen peroxide-induced calcium inf… |
1 mg |
37447-1 |
More Info
|
Tat-M2NX (trifluoroacetate salt) |
A peptide TRPM2 antagonist; inhibits hydrogen peroxide-induced calcium inf… |
10 mg |
37447-10 |
More Info
|
Tat-M2NX (trifluoroacetate salt) |
A peptide TRPM2 antagonist; inhibits hydrogen peroxide-induced calcium inf… |
5 mg |
37447-5 |
More Info
|
Tat-NTS Peptide (trifluoroacetate salt) |
A cell-penetrating peptide; blocks the protein-protein interaction between… |
1 mg |
37443-1 |
More Info
|
Tat-NTS Peptide (trifluoroacetate salt) |
A cell-penetrating peptide; blocks the protein-protein interaction between… |
10 mg |
37443-10 |
More Info
|
Tat-NTS Peptide (trifluoroacetate salt) |
A cell-penetrating peptide; blocks the protein-protein interaction between… |
25 mg |
37443-25 |
More Info
|
Tat-NTS Peptide (trifluoroacetate salt) |
A cell-penetrating peptide; blocks the protein-protein interaction between… |
5 mg |
37443-5 |
More Info
|
Tat-QFNP12 (trifluoroacetate salt) |
A peptide inhibitor of the NDRG2-PPM1A protein-protein interaction; decrea… |
1 mg |
38845-1 |
More Info
|
Tat-QFNP12 (trifluoroacetate salt) |
A peptide inhibitor of the NDRG2-PPM1A protein-protein interaction; decrea… |
10 mg |
38845-10 |
More Info
|
Tat-QFNP12 (trifluoroacetate salt) |
A peptide inhibitor of the NDRG2-PPM1A protein-protein interaction; decrea… |
25 mg |
38845-25 |
More Info
|
Tat-QFNP12 (trifluoroacetate salt) |
A peptide inhibitor of the NDRG2-PPM1A protein-protein interaction; decrea… |
5 mg |
38845-5 |
More Info
|
Tat (2-4) (trifluoroacetate salt) |
A peptide |
1 mg |
37445-1 |
More Info
|
Tat (2-4) (trifluoroacetate salt) |
A peptide |
10 mg |
37445-10 |
More Info
|
Tat (2-4) (trifluoroacetate salt) |
A peptide |
25 mg |
37445-25 |
More Info
|
Tat (2-4) (trifluoroacetate salt) |
A peptide |
5 mg |
37445-5 |
More Info
|
Tat (48-60) (trifluoroacetate salt) |
A peptide |
10 mg |
37499-10 |
More Info
|
Tat (48-60) (trifluoroacetate salt) |
A peptide |
25 mg |
37499-25 |
More Info
|
Tat (48-60) (trifluoroacetate salt) |
A peptide |
5 mg |
37499-5 |
More Info
|
Tat (48-60) (trifluoroacetate salt) |
A peptide |
50 mg |
37499-50 |
More Info
|
τ-Fluvalinate |
A pyrethroid acaricide; induces tail currents in AmNav1 and VdNav1 channel… |
100 mg |
34520-100 |
More Info
|
τ-Fluvalinate |
A pyrethroid acaricide; induces tail currents in AmNav1 and VdNav1 channel… |
25 mg |
34520-25 |
More Info
|
τ-Fluvalinate |
A pyrethroid acaricide; induces tail currents in AmNav1 and VdNav1 channel… |
50 mg |
34520-50 |
More Info
|
Taurine |
A sulfur-containing amino acid; scavenges DPPH radicals at 125-1,000 &micr… |
100 g |
27031-100 |
More Info
|
Taurine |
A sulfur-containing amino acid; scavenges DPPH radicals at 125-1,000 &micr… |
250 g |
27031-250 |
More Info
|
Taurine |
A sulfur-containing amino acid; scavenges DPPH radicals at 125-1,000 &micr… |
500 g |
27031-500 |
More Info
|
Taurine-d4 |
An internal standard for the quantification of taurine by GC- or LC-MS |
1 mg |
35211-1 |
More Info
|
Taurine-d4 |
An internal standard for the quantification of taurine by GC- or LC-MS |
10 mg |
35211-10 |
More Info
|
Taurine-d4 |
An internal standard for the quantification of taurine by GC- or LC-MS |
5 mg |
35211-5 |
More Info
|
Taurine-d4 |
An internal standard for the quantification of taurine by GC- or LC-MS |
500 µg |
35211-500 |
More Info
|
Tauro-α-muricholic Acid-d4 (sodium salt) |
An internal standard for the quantification of tauro-α-muricholic ac… |
1 mg |
27039-1 |
More Info
|
Tauro-α-muricholic Acid-d4 (sodium salt) |
An internal standard for the quantification of tauro-α-muricholic ac… |
500 µg |
27039-500 |
More Info
|
Tauro-α-muricholic Acid (sodium salt) |
An FXR receptor antagonist (IC50 = 28 µM); a taurine-conjugated form… |
1 mg |
20288-1 |
More Info
|
Tauro-β-muricholic Acid-d4 (sodium salt) |
An internal standard for the quantification of tauro-β-muricholic aci… |
1 mg |
27040-1 |
More Info
|
Tauro-β-muricholic Acid (sodium salt) |
An FXR receptor antagonist (IC50 = 40 µM); a taurine-conjugated form… |
1 mg |
20289-1 |
More Info
|
Tauro-β-muricholic Acid (sodium salt) |
An FXR receptor antagonist (IC50 = 40 µM); a taurine-conjugated form… |
5 mg |
20289-5 |
More Info
|
Tauro-β-muricholic Acid (sodium salt) |
An FXR receptor antagonist (IC50 = 40 µM); a taurine-conjugated form… |
500 µg |
20289-500 |
More Info
|
Taurochenodeoxycholic Acid-d4 MaxSpec® Standard |
A quantitative analytical standard guaranteed to meet MaxSpec® identit… |
100 µg |
31362-100 |
More Info
|
Taurochenodeoxycholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurochenodeoxycholic acid… |
1 mg |
21905-1 |
More Info
|
Taurochenodeoxycholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurochenodeoxycholic acid… |
5 mg |
21905-5 |
More Info
|
Taurochenodeoxycholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurochenodeoxycholic acid… |
500 µg |
21905-500 |
More Info
|
Taurochenodeoxycholic Acid MaxSpec® Standard |
A quantitative analytical standard guaranteed to meet MaxSpec® identit… |
100 µg |
31361-100 |
More Info
|
Taurochenodeoxycholic Acid (sodium salt) |
A taurine-conjugated form of CDCA; serum levels increase approximately 5-f… |
1 g |
20275-1 |
More Info
|
Taurochenodeoxycholic Acid (sodium salt) |
A taurine-conjugated form of CDCA; serum levels increase approximately 5-f… |
100 mg |
20275-100 |
More Info
|
Taurochenodeoxycholic Acid (sodium salt) |
A taurine-conjugated form of CDCA; serum levels increase approximately 5-f… |
50 mg |
20275-50 |
More Info
|
Taurochenodeoxycholic Acid (sodium salt) |
A taurine-conjugated form of CDCA; serum levels increase approximately 5-f… |
500 mg |
20275-500 |
More Info
|
Taurocholic Acid-d4 MaxSpec® Standard |
A quantitative analytical standard guaranteed to meet MaxSpec® identit… |
100 µg |
31375-100 |
More Info
|
Taurocholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurocholic acid by GC- or… |
1 mg |
21891-1 |
More Info
|
Taurocholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurocholic acid by GC- or… |
5 mg |
21891-5 |
More Info
|
Taurocholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurocholic acid by GC- or… |
500 µg |
21891-500 |
More Info
|
Taurocholic Acid MaxSpec® Standard |
A quantitative analytical standard guaranteed to meet MaxSpec® identit… |
100 µg |
31374-100 |
More Info
|
Taurocholic Acid (sodium salt) |
A taurine-conjugated form of cholic acid; serum levels of TCA are decrease… |
1 g |
16215-1 |
More Info
|
Taurocholic Acid (sodium salt) |
A taurine-conjugated form of cholic acid; serum levels of TCA are decrease… |
10 g |
16215-10 |
More Info
|
Taurocholic Acid (sodium salt) |
A taurine-conjugated form of cholic acid; serum levels of TCA are decrease… |
25 g |
16215-25 |
More Info
|
Taurocholic Acid (sodium salt) |
A taurine-conjugated form of cholic acid; serum levels of TCA are decrease… |
5 g |
16215-5 |
More Info
|
Taurocholic Acid 3-sulfate (sodium salt) |
A metabolite of taurocholic acid; plasma levels are elevated in wild-type… |
1 mg |
9002538-1 |
More Info
|
Taurocholic Acid 3-sulfate (sodium salt) |
A metabolite of taurocholic acid; plasma levels are elevated in wild-type… |
10 mg |
9002538-10 |
More Info
|
Taurocholic Acid 3-sulfate (sodium salt) |
A metabolite of taurocholic acid; plasma levels are elevated in wild-type… |
5 mg |
9002538-5 |
More Info
|
Taurocholic Acid 3-sulfate (sodium salt) |
A metabolite of taurocholic acid; plasma levels are elevated in wild-type… |
500 µg |
9002538-500 |
More Info
|
Taurodeoxycholic Acid-d4 MaxSpec® Standard |
A quantitative analytical standard guaranteed to meet MaxSpec® identit… |
100 µg |
31563-100 |
More Info
|
Taurodeoxycholic Acid-d4 (sodium salt) |
An internal standard for the quantification of taurodeoxycholic acid by GC… |
1 mg |
32983-1 |
More Info
|